Cypress Asset Management Inc. TX Makes New Investment in Agilent Technologies, Inc. (NYSE:A)

Cypress Asset Management Inc. TX acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 4,194 shares of the medical research company’s stock, valued at approximately $583,000.

Other large investors have also recently bought and sold shares of the company. MV Capital Management Inc. lifted its stake in shares of Agilent Technologies by 120.7% in the 4th quarter. MV Capital Management Inc. now owns 192 shares of the medical research company’s stock valued at $27,000 after purchasing an additional 105 shares during the period. VisionPoint Advisory Group LLC acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $29,000. Baystate Wealth Management LLC lifted its stake in shares of Agilent Technologies by 107.3% in the 4th quarter. Baystate Wealth Management LLC now owns 257 shares of the medical research company’s stock valued at $36,000 after purchasing an additional 133 shares during the period. Rosenberg Matthew Hamilton raised its stake in Agilent Technologies by 51.1% during the 4th quarter. Rosenberg Matthew Hamilton now owns 284 shares of the medical research company’s stock worth $39,000 after buying an additional 96 shares during the period. Finally, Turtle Creek Wealth Advisors LLC acquired a new stake in Agilent Technologies during the 4th quarter worth $39,000.

Analyst Upgrades and Downgrades

A has been the subject of a number of research reports. Oppenheimer increased their target price on Agilent Technologies from $67.00 to $90.00 and gave the stock an “outperform” rating in a report on Tuesday, March 26th. Stifel Nicolaus upgraded Agilent Technologies from a “hold” rating to a “buy” rating and increased their target price for the stock from $145.00 to $163.00 in a report on Friday, April 5th. Citigroup increased their target price on Agilent Technologies from $130.00 to $145.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. UBS Group increased their target price on Agilent Technologies from $130.00 to $155.00 and gave the stock a “neutral” rating in a report on Wednesday, February 28th. Finally, Evercore ISI increased their target price on Agilent Technologies from $132.00 to $145.00 and gave the stock an “in-line” rating in a report on Thursday, April 4th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $141.29.

Agilent Technologies Price Performance

Shares of NYSE A traded down $0.42 during midday trading on Friday, reaching $150.13. The company’s stock had a trading volume of 363,014 shares, compared to its average volume of 1,502,502. The company has a debt-to-equity ratio of 0.41, a quick ratio of 2.04 and a current ratio of 2.68. Agilent Technologies, Inc. has a fifty-two week low of $96.80 and a fifty-two week high of $155.35. The business’s 50 day moving average price is $144.00 and its two-hundred day moving average price is $135.71. The company has a market cap of $44.00 billion, a P/E ratio of 35.84, a P/E/G ratio of 4.10 and a beta of 1.13.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Tuesday, February 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.22 by $0.07. The business had revenue of $1.66 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a return on equity of 27.09%. The firm’s quarterly revenue was down 5.5% compared to the same quarter last year. During the same period last year, the firm posted $1.37 earnings per share. On average, analysts forecast that Agilent Technologies, Inc. will post 5.5 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd will be paid a dividend of $0.236 per share. The ex-dividend date of this dividend is Tuesday, July 2nd. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.63%. Agilent Technologies’s payout ratio is presently 22.38%.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction on Monday, March 25th. The shares were sold at an average price of $147.54, for a total transaction of $417,095.58. Following the sale, the senior vice president now owns 9,997 shares of the company’s stock, valued at $1,474,957.38. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Michael R. Mcmullen sold 52,297 shares of the business’s stock in a transaction on Friday, March 8th. The shares were sold at an average price of $150.00, for a total value of $7,844,550.00. Following the sale, the chief executive officer now owns 253,909 shares of the company’s stock, valued at $38,086,350. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Philip Binns sold 2,827 shares of the business’s stock in a transaction on Monday, March 25th. The stock was sold at an average price of $147.54, for a total transaction of $417,095.58. Following the completion of the sale, the senior vice president now directly owns 9,997 shares in the company, valued at approximately $1,474,957.38. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 61,610 shares of company stock valued at $9,220,333.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.